Literature DB >> 25313451

Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease.

Randall E Keyser1, Joshua G Woolstenhulme, Lisa M K Chin, Steven D Nathan, Nargues A Weir, Gerilynn Connors, Bart Drinkard, James Lamberti, Leighton Chan.   

Abstract

PURPOSE: To characterize the cardiorespiratory response to exercise before and after aerobic exercise training in patients with interstitial lung disease.
METHODS: We performed a clinical study, examining 13 patients (New York Heart Association/World Health Organization Functional class II or III) before and after 10 weeks of supervised treadmill exercise walking, at 70% to 80% of heart rate reserve, 30 to 45 minutes per session, 3 times a week. Outcome variables included measures of cardiorespiratory function during a treadmill cardiopulmonary exercise test, with additional near infrared spectroscopy measurements of peripheral oxygen extraction and bioimpedance cardiography measurements of cardiac output. Six-minute walk test distance was also measured.
RESULTS: All subjects participated in at least 24 of their 30 scheduled exercise sessions with no significant adverse events. After training, the mean 6-minute walk test distance increased by 52 ± 48 m (P = .001), peak treadmill cardiopulmonary exercise test time increased by 163 ± 130 s (P = .001), and time to achieve gas exchange threshold increased by 145 ± 37 s (P < .001). Despite a negligible increase in peak (Equation is included in full-text article.)o2 with no changes to cardiac output, the overall work rate/(Equation is included in full-text article.)o2 relationship was enhanced after training. Muscle O2 extraction increased by 16% (P = .049) after training.
CONCLUSIONS: Clinically significant improvements in cardiorespiratory function were observed after aerobic exercise training in this group of subjects with interstitial lung disease. These improvements appear to have been mediated by increases in the peripheral extraction of O2 rather than changes in O2 delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25313451      PMCID: PMC4276491          DOI: 10.1097/HCR.0000000000000083

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  41 in total

Review 1.  The effect of endurance training on parameters of aerobic fitness.

Authors:  A M Jones; H Carter
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  The effects of training on heart rate; a longitudinal study.

Authors:  M J KARVONEN; E KENTALA; O MUSTALA
Journal:  Ann Med Exp Biol Fenn       Date:  1957

Review 4.  Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines.

Authors:  Andrew L Ries; Gerene S Bauldoff; Brian W Carlin; Richard Casaburi; Charles F Emery; Donald A Mahler; Barry Make; Carolyn L Rochester; Richard Zuwallack; Carla Herrerias
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

5.  2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

6.  Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease.

Authors:  S Foster; H M Thomas
Journal:  Am Rev Respir Dis       Date:  1990-03

7.  Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease.

Authors:  Gregory Ferreira; Martin Feuerman; Peter Spiegler
Journal:  J Cardiopulm Rehabil       Date:  2006 Jan-Feb       Impact factor: 2.081

8.  Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).

Authors:  Robert J Mentz; Phillip J Schulte; Jerome L Fleg; Mona Fiuzat; William E Kraus; Ileana L Piña; Steven J Keteyian; Dalane W Kitzman; David J Whellan; Stephen J Ellis; Christopher M O'Connor
Journal:  Am Heart J       Date:  2012-11-28       Impact factor: 4.749

Review 9.  Dyspnea in interstitial lung disease.

Authors:  Harold R Collard; Steven Z Pantilat
Journal:  Curr Opin Support Palliat Care       Date:  2008-06       Impact factor: 2.302

Review 10.  Cardiopulmonary exercise testing in interstitial lung disease.

Authors:  C F Donner; M Carone; A Patessio; L Appendini
Journal:  Z Kardiol       Date:  1994
View more
  4 in total

Review 1.  Exercise training in idiopathic pulmonary fibrosis: is it of benefit?

Authors:  Baruch Vainshelboim
Journal:  Breathe (Sheff)       Date:  2016-06

Review 2.  Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible.

Authors:  Elisabetta Balestro; Elisabetta Cocconcelli; Mariaenrica Tinè; Davide Biondini; Eleonora Faccioli; Marina Saetta; Federico Rea
Journal:  Medicina (Kaunas)       Date:  2019-10-19       Impact factor: 2.430

3.  Skeletal muscle oxygenation and regional blood volume during incremental limb loading in interstitial lung disease.

Authors:  Lisa Wickerson; Sunita Mathur; Dina Brooks; L V Bonetti; Lianne G Singer; John Granton; W Darlene Reid
Journal:  ERJ Open Res       Date:  2020-01-27

Review 4.  IPF Respiratory Symptoms Management - Current Evidence.

Authors:  Piotr Janowiak; Amelia Szymanowska-Narloch; Alicja Siemińska
Journal:  Front Med (Lausanne)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.